VSee Health, Inc. received a notice from Nasdaq on July 30, 2026, that its securities will be delisted from the Nasdaq Capital Market due to a closing bid price of $0.10 or less for ten consecutive trading days. Trading of common stock and warrants is suspended at the opening of business on August 6, 2026. The company may appeal by submitting a request and a non-refundable fee of $20,000 to the Nasdaq Hearings Panel no later than 4:00 p.m. Eastern Time on August 6, 2026. VSee Health operates in the healthcare technology industry.

VSee Health, Inc. entered into a securities purchase agreement with Labrys on June 30, 2026, issuing an unsecured convertible promissory note with an aggregate principal amount of $336,000, which includes a $36,000 original issue discount. The note bears a one-time interest charge of twelve percent and is due on June 30, 2027. Conversion into common stock is permitted after the earlier of default, 180 days post-issuance, or registration of conversion shares, at a price equal to 75% of the lowest closing bid price over the preceding ten trading days. The company operates in the healthcare technology sector.